Article Information
History
- April 7, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Ron Handels1,2,*,
- William L. Herring2,3,
- Sabine Grimm4,
- Anders Sköldunger2,
- Bengt Winblad2,5,
- Anders Wimo2 and
- Linus Jönsson2
- 1Maastricht University; Alzheimer Centre Limburg; Faculty of Health, Medicine and Life Sciences; Mental Health and Neuroscience Research Institute; Department of Psychiatry and Neuropsychology; 6200 MD, Maastricht, The Netherlands
- 2Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, BioClinicum J9:20, Akademiska stråket 171 64 Solna, Sweden
- 3Health Economics, RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, NC 27709, USA
- 4Maastricht University Medical Centre, Department of Clinical Epidemiology and Medical Technology Assessment, School for Public Health and Primary Care (CAPHRI), P. Debyelaan 25, PO Box 5800, 6202 AZ Maastricht, The Netherlands
- 5Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden
- ↵*CORRESPONDING AUTHOR Ron Handels, Maastricht University, affiliated to Karolinska Institutet ron.handels{at}maastrichtuniversity.nl
Posted April 07, 2024.
New IPECAD open-source model framework for the health technology assessment of early Alzheimer’s disease treatment: development and use cases
